EP0297866A2 — Therapeutic agents
Assigned to Boots Co PLC · Expires 1989-01-04 · 37y expired
What this patent protects
Sustained release granules of ibuprofen comprising a homogeneous mixture of ibuprofen and a pharmaceutically acceptable polymeric material, operable to provide a slow release of ibuprofen over a pH range from 1.0 to 7.0, the polymeric material being present in an amount of 5% to …
USPTO Abstract
Sustained release granules of ibuprofen comprising a homogeneous mixture of ibuprofen and a pharmaceutically acceptable polymeric material, operable to provide a slow release of ibuprofen over a pH range from 1.0 to 7.0, the polymeric material being present in an amount of 5% to 25% by weight, based on the weight of the ibuprofen. The granules are prepared by dissolving the ibuprofen and polymeric material in a solvent and evaporating the solvent. Suitable polymeric materials include ethyl cellulose, high viscosity hydroxy propyl methyl cellulose and copolymers of dimethyl aminoethyl methylacrylate and methacrylic acid ester. The granules may be compressed to form sustained release tablets.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.